Menu
GWAS Study

Whole genome sequencing of 4,787 individuals identifies gene-based rare variants in age-related macular degeneration.

Kwong A, Zawistowski M, Fritsche LG et al.

37934784 PubMed ID
GWAS Study Type
4787 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KA
Kwong A
ZM
Zawistowski M
FL
Fritsche LG
ZX
Zhan X
BJ
Bragg-Gresham J
BK
Branham KE
AJ
Advani J
OM
Othman M
RR
Ratnapriya R
TT
Teslovich TM
SD
Stambolian D
CE
Chew EY
AG
Abecasis GR
SA
Swaroop A
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies have contributed extensively to the discovery of disease-associated common variants. However, the genetic contribution to complex traits is still largely difficult to interpret. We report a genome-wide association study of 2394 cases and 2393 controls for age-related macular degeneration (AMD) via whole-genome sequencing, with 46.9 million genetic variants. Our study reveals significant single-variant association signals at four loci and independent gene-based signals in CFH, C2, C3, and NRTN. Using data from the Exome Aggregation Consortium (ExAC) for a gene-based test, we demonstrate an enrichment of predicted rare loss-of-function variants in CFH, CFI, and an as-yet unreported gene in AMD, ORMDL2. Our method of using a large variant list without individual-level genotypes as an external reference provides a flexible and convenient approach to leverage the publicly available variant datasets to augment the search for rare variant associations, which can explain additional disease risk in AMD.

2,394 European ancestry cases, 2,393 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

4787
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.